摘要
选取 94例新诊断青年 2型糖尿病患者 (2 0~ 44岁 ) ,分别接受阿卡波糖、二甲双胍、格列吡嗪治疗 3 6周 ,结果显示 3组药物有相似的降糖效果 ,但阿卡波糖可减低餐后胰岛素分泌 ,安全性及依从性更好 ,适合初诊断的青年
Ninty-four newly diagnosed young type 2 diabetic patients were treated by acarbose, metformin or glipizide for 36 weeks. The results showed that these drugs had similar effects in reducing blood glucose. Acabose decreased postprandial insulin secretion and had higher safety and better compliance. It was appropriate to use in newly diagnosed young type 2 diabetic patients.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2004年第5期449-450,共2页
Chinese Journal of Endocrinology and Metabolism